Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.3200 (0.03%) ($18.3200 - $18.3200) on Mon. Nov. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.5% (three month average) | RSI | 58 | Latest Price | $18.3200(0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(47%) ARKG(46%) ARKK(46%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.75% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-16%) USO(-11%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.75% (StdDev 3.5%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $17.91(2.29%) | 10 Day Moving Average | $17.7(3.5%) | 20 Day Moving Average | $17.37(5.47%) | To recent high | -7.9% | To recent low | 35.4% | Market Cap | $1.361b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |